Castlekeep Investment Advisors LLC Buys New Stake in Danaher Corporation $DHR

Castlekeep Investment Advisors LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 5,268 shares of the conglomerate's stock, valued at approximately $1,003,000.

Several other hedge funds also recently added to or reduced their stakes in DHR. High Note Wealth LLC boosted its position in shares of Danaher by 19.2% in the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate's stock worth $67,000 after buying an additional 47 shares during the period. First Command Advisory Services Inc. raised its holdings in shares of Danaher by 4.4% during the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate's stock valued at $253,000 after buying an additional 47 shares during the period. GW&K Investment Management LLC lifted its position in Danaher by 8.4% during the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate's stock worth $138,000 after acquiring an additional 47 shares in the last quarter. Kestra Private Wealth Services LLC lifted its position in Danaher by 0.3% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate's stock worth $3,057,000 after acquiring an additional 48 shares in the last quarter. Finally, SOL Capital Management CO grew its position in Danaher by 2.7% in the fourth quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate's stock valued at $430,000 after acquiring an additional 50 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on DHR shares. Piper Sandler assumed coverage on shares of Danaher in a research report on Thursday, June 11th. They set a "neutral" rating and a $200.00 target price on the stock. DZ Bank assumed coverage on shares of Danaher in a report on Wednesday, June 3rd. They set a "buy" rating and a $210.00 price target for the company. Evercore reiterated an "outperform" rating and issued a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. Wolfe Research cut shares of Danaher from an "outperform" rating to a "peer perform" rating in a research report on Monday, June 1st. Finally, Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $240.00 target price on shares of Danaher in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $228.91.

Danaher Price Performance

Shares of DHR stock opened at $215.78 on Wednesday. The firm has a fifty day moving average of $197.17 and a two-hundred day moving average of $192.36. The firm has a market cap of $151.69 billion, a P/E ratio of 38.33, a P/E/G ratio of 2.68 and a beta of 0.78. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company's quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.77 earnings per share. As a group, research analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source